These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6480450

  • 1. The effect in the KHT sarcoma of CCNU and MISO on cell cycle progression evaluated by flow-cytometry.
    Hill SA, Bauer KD, Keng PC, Siemann DW.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1619-22. PubMed ID: 6480450
    [Abstract] [Full Text] [Related]

  • 2. Survival in subpopulations of cells derived from solid KHT sarcomas by centrifugal elutriation following treatment with CCNU and MISO.
    Hill SA, Keng PC, Siemann DW.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1615-8. PubMed ID: 6480449
    [Abstract] [Full Text] [Related]

  • 3. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
    Siemann DW, Hill SA.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
    [Abstract] [Full Text] [Related]

  • 4. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW, Maddison K, Wolf K, Hill SA, Keng PC.
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [Abstract] [Full Text] [Related]

  • 5. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT, Siemann DW.
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [Abstract] [Full Text] [Related]

  • 6. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW.
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [Abstract] [Full Text] [Related]

  • 7. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW, Morrissey S, Wolf K.
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [Abstract] [Full Text] [Related]

  • 8. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
    Siemann DW.
    Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
    [Abstract] [Full Text] [Related]

  • 9. Combinations of CCNU, MISO, and fractionated radiotherapy.
    Siemann DW, Alliet KL.
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1379-82. PubMed ID: 3759559
    [Abstract] [Full Text] [Related]

  • 10. Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
    Lee FY, Workman P.
    Br J Cancer; 1984 May; 49(5):579-85. PubMed ID: 6722006
    [Abstract] [Full Text] [Related]

  • 11. Chemopotentiation in vivo: no loss of sensitization with fractionation.
    Hill SA, Siemann DW.
    Br J Cancer; 1984 Oct; 50(4):509-17. PubMed ID: 6487517
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of misonidazole chemopotentiation by mild hyperthermia (41 degrees C) in vitro and selective enhancement in vivo.
    Mulcahy RT, Gipp JJ, Tanner MA.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):57-65. PubMed ID: 3496311
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of combination chemotherapy by nitroheterocyclics.
    Siemann DW, Allalunis-Turner MJ.
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):129-34. PubMed ID: 3391809
    [Abstract] [Full Text] [Related]

  • 14. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.
    Workman P, Twentyman PR.
    Br J Cancer; 1982 Aug; 46(2):249-59. PubMed ID: 7150475
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of CCNU activity by misonidazole in metastases.
    Siemann DW, Alliet KL.
    Clin Exp Metastasis; 1987 Aug; 5(1):57-63. PubMed ID: 3829497
    [Abstract] [Full Text] [Related]

  • 16. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT.
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [Abstract] [Full Text] [Related]

  • 17. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY, Workman P.
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [Abstract] [Full Text] [Related]

  • 18. Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
    Durand RE, Chaplin DJ.
    Br J Cancer; 1987 Aug; 56(2):103-9. PubMed ID: 3663461
    [Abstract] [Full Text] [Related]

  • 19. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
    Siemann DW, Maddison K, Wolf K.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
    [Abstract] [Full Text] [Related]

  • 20. Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Hirst DG, Brown JM, Hazlehurst JL.
    Cancer Res; 1983 May; 43(5):1961-5. PubMed ID: 6682009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.